Corporate Information And Statement Of Ifrs Compliance [Abstract]

BioPorto - Filing #5888346

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2023-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification
BioPorto A/S
Legal form of entity
A/S
Address of entity's registered office
T
Principal place of business
Denmark
Description of nature of entity's operations and principal activities
BioPorto is an in vitro diagnostics company  
Explanation of why entity not regarded as going concern
The Company assessed its liquidity and capital resources  
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current inventories
4,640,000 DKK
3,787,000 DKK
Current trade receivables
8,187,000 DKK
2,346,000 DKK
Current trade payables
5,706,000 DKK
6,905,000 DKK
Disclosure of material accounting policy information [text block]
The accounting policies set out below have been used  

Talk to a Data Expert

Have a question? We'll get back to you promptly.